CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $80 | +6.7% | 3,705 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $75 | -99.9% | 3,705 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $95,000 | -20.2% | 3,705 | -38.4% | 0.00% | 0.0% |
| Q4 2021 | $119,000 | -40.8% | 6,010 | -41.1% | 0.00% | -42.9% |
| Q3 2021 | $201,000 | -10.3% | 10,200 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $224,000 | -7.8% | 10,200 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $243,000 | -9.0% | 10,200 | 0.0% | 0.01% | -18.2% |
| Q4 2020 | $267,000 | +50.0% | 10,200 | 0.0% | 0.01% | +37.5% |
| Q3 2020 | $178,000 | +3.5% | 10,200 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $172,000 | – | 10,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |